Your browser doesn't support javascript.
loading
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
Annaratone, Laura; Simonetti, Michele; Wernersson, Erik; Marchiò, Caterina; Garnerone, Silvano; Scalzo, Maria Stella; Bienko, Magda; Chiarle, Roberto; Sapino, Anna; Crosetto, Nicola.
Afiliación
  • Annaratone L; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Simonetti M; Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Karolinska Institutet, Stockholm, Sweden.
  • Wernersson E; Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Karolinska Institutet, Stockholm, Sweden.
  • Marchiò C; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Garnerone S; Department of Laboratory Medicine, Pathology Unit, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy.
  • Scalzo MS; Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Karolinska Institutet, Stockholm, Sweden.
  • Bienko M; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Chiarle R; Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Karolinska Institutet, Stockholm, Sweden.
  • Sapino A; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Crosetto N; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Oncotarget ; 8(12): 18680-18698, 2017 Mar 21.
Article en En | MEDLINE | ID: mdl-28423635
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos / Biomarcadores de Tumor / Hibridación Fluorescente in Situ / Receptor ErbB-2 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos / Biomarcadores de Tumor / Hibridación Fluorescente in Situ / Receptor ErbB-2 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Italia